title: [Pharmacologic correction of the cellular immunity disorders in infants in the 1st 3 months of life with escherichiosis].
abstract: Seventy-five children in the first three months of life with escherichiosis were studied. It was found that levamisole to a lesser degree and methyluracyl decrease total duration of the disease by shortening periods of disorders of the gastrointestinal tract functions and bacterial excretions; the drugs improved indices of the condition of the cellular link of the immunity system.
mesh_terms: D003131:Combined Modality Therapy; D004341:Drug Evaluation; D004927:Escherichia coli Infections / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007223:Infant; D007410:Intestinal Diseases / Q000188:drug therapy* / Q000276:immunology; D007978:Levamisole / Q000627:therapeutic use; D014498:Uracil / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D007978:Levamisole; D014498:Uracil; C008378:6-methyluracil
vernacular_title: Farmakologicheskaia korrektsiia narusheniĭ kletochnogo immuniteta u bol'nykh éhserikhiozom deteĭ pervykh 3 mes zhizni.